Particle.news
Health ❯ Healthcare ❯ Cancer Research
Patient Outcomes Preclinical Studies Targeted Therapy Therapeutic Innovations Drug Development Prostate Cancer Studies COMET Study Proof-of-Concept Trials Treatment Strategies Patient Monitoring Saliva Tests for Cancer Genetic Testing FDA Approvals Molecular Testing Nivolumab Immunotherapy Development Precision Medicine Immunotherapy Research Retrospective Studies Randomized Controlled Trials Therapeutic Vaccines Immunotherapy Treatment Efficacy Metastasis Prevention Patient Support Preclinical Research Density MATTERS Trial Innovative Diagnostics Phase II Trials Survival Rates Early Detection Aspirin Treatment Guideline Development ALASCCA Study Funding Impact Olaparib Surveillance Programs Experimental Studies Treatment Options NHS Galleri Trial Funding Sources Public Involvement Dietary Interventions Therapeutic Development
The Nature Materials study reports week-long, tumor-localized IL-12 delivery that overcame immunotherapy resistance in metastatic models.
